Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.72
+0.05 (0.75%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +138.10% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +63.69% | Aug 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $19 | Buy | Reiterates | $19 | +182.74% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 | Buy | Maintains | $17 | +152.98% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $25 | Buy | Reiterates | $25 | +272.02% | Aug 12, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $14 | Buy | Maintains | $14 | +108.33% | Aug 3, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $14 | Buy | Reiterates | $14 | +108.33% | May 5, 2026 |